-
PRISMA Questionnaire data
The extensive questionnaire covers a number of potential breast cancer risk predictors such as demographics, personal characteristics, reproductive characteristics, medication,... -
300-Obese cohort gut microbiome data
300-Obese cohort was recruited at the Radboud University Medical Center (RUMC), Nijmegen, the Netherlands. The cohort comprises 377 participants included by the following... -
PRISMA Imaging data
The PRISMA imaging data consists of both processed and unprocessed screening mammograms (two views of each breast for each participant) obtained at study entry. -
PRIDE Study pharmacy data
Details on prescription medication fills in the three months before the last menstrual period until 6 months after the estimated date of delivery. Necessitates additional... -
PRIDE Study paternal questionnaire data
Questionnaire data focusing on paternal exposures the 3 months before conception. Completed by the biological father, <50% participation rate. -
POM imaging data
Imaging data of the Personalized Parkinson Project, including structural and functional MRI. -
PRIDE Study questionnaire data
In this ongoing prospective cohort study, women complete web-based questionnaires at three time points in pregnancy (at enrollment [median gestational age 10 weeks], gestational... -
PRIDE Study obstetric records
Selected clinical data from obstetric records covering the pregnancy period and puerperium. Necessitates additional consent, provided by ~70% of participants -
UroLife study quality of life questionnaire
The EORTC QLQ-C30 and EORTC QLQ-NMIBC24 was completed at 6 weeks (n=1451) and 3 (n=1334), 15 (n=1159) and 51 months (n=588) after diagnosis. -
ReLife study general questionnaire
Patients with localized stage I-III renal cell cancer (n=365) completed paper-and-pencil or web-based questionnaires at 3 months (n=368), 12 months (n=317), and 24 months... -
UroLife study blood samples
EDTA and heparin plasma samples were collected at 3 (n=1280) and 15 months (n=1122) after diagnosis. Heparin plasma samples have been analysed for carotenoids at 3 and 15 months... -
UroLife study food frequency questionnaire
A 163-item Food Frequency questionnaire was completed at 6 weeks (referring to pre-diagnosis lifestyle; n=1439)) and 3 (n=1316), 15 (n=1143) en 51 months (n<589) after... -
POM biomaterials
Biomaterials of the Personalized Parkinson Project, including blood, CSF and stool samples. -
PRIDE Study medication diaries
6-week medication diaries covering prescription and over-the counter use, administered in the second trimester of pregnancy. Available for 1516 PRIDE Study participants... -
UroLife study general questionnaire
Patients with non-muscle invasive bladder cancer (n=1512) completed paper-and-pencil or web-based questionnaires at 6 weeks (referring to pre-diagnosis lifestyle; n=1486) and 3... -
PRIDE Study nutrition
Food frequency questionnaire administered in early pregnancy, assessing multiple macronutrients and micronutrients. -
PRIDE Study saliva samples
Single saliva samples for cortisol analyses collected in 2012-2020 in subgroup (N~3400). Partially analyzed, remaining samples stored at -20°C. -
UroLife study fluid intake and micturition diary
A 4-day fluid and micturition diary was completed at 3 (n=1146) and 15 months (n=1000) after diagnosis. -
ReLife study food frequency questionnaire
A 163-item Food Frequency questionnaire was completed at 3 (n=352), 12 (n=330) and 24 months (n=275) after surgery. -
PRIDE Study blood samples
First trimester blood samples (plasma, serum, whole blood) of ~1000 PRIDE Study participants, available for genetic and biochemical analyses. Stored at -80°C.